DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 93 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Negative impactCorporate Action

Saroja Pharma Industries India Limited — Resignation

NSE 50 min ago·5 Oct 2026, 12:55 pm

Saroja Pharma Industries India

Saroja Pharma Industries India Limited has announced that Mr. Ravindra Shivaji Salaskar has resigned as a Whole-time Director of the company, effective October 05, 2026. This move comes as part of a standard corporate governance practice where key personnel may step down to pursue other opportunities or for personal reasons.

For investors, this development is a routine administrative update rather than a signal of operational trouble. Since the resignation date is in the future, the company has time to appoint a replacement. Investors should focus on the company's future business performance and financial health rather than this single personnel change.

What to watch next is the company's announcement regarding the appointment of a new director to fill the vacancy. This will ensure continuity in the company's leadership and strategic direction.

Affected stocks

Bearish1 stock

Saroja Pharma Industries India

SAROJA Bearish

₹40.80

Bull / bear label is derived from the article's AI sentiment — indicative, not advice. Prices may be delayed.

Key takeaways

Concerns Saroja Pharma Industries India (SAROJA).
Category: Corporate Action.
AI reads the tone as negative (potentially bearish) for the stock.

Why it matters

A routine update for Saroja Pharma Industries India. The tone is negative — watch for downside reaction. Use the price and stock snapshot to gauge how the market is responding.

Summary & analysis by DocStoX. Full story at NSE.